Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine
Macromolecular Rapid Communications · 2026-06 · 47 (11)
DOI: 10.1002/marc.70258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Rapid Communications, online erschienen am 15.03.2026. Verfasst von Yongchao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute…. Hauptthemen laut MEDLINE: Doxorubicin, Tumor Microenvironment, Dendrimers, Nanomedicine. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of China, Department of Science and Technology of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
A linear‐dendritic polymer has been explored as a drug delivery vehicle for cancer therapy. In this study, we successfully prepared a tumor microenvironment‐responsive, dendronized and block poly[ N ‐(2‐hydroxypropyl) methacrylamide] (polyHPMA)‐based copolymer‐doxorubicin conjugate (pHPMA‐block‐pDendron‐DOX) via two‐step reversible addition‐fragmentation chain transfer (RAFT) polymerization. The conjugate self‐assembled into nanoparticles (NPs). Due to the presence of the Gly‐Phe‐Leu‐Gly (GFLG) tetrapeptide and the hydrazone bond in the structure of the conjugate, cathepsin B‐responsive degradation and pH‐responsive drug release were realized within the tumor microenvironment. The NPs displayed a distinctive cytotoxic effect on 4T1 cells after internalization through endocytosis pathways. Significant improvements in the accumulation of doxorubicin (DOX) from the NPs were observed at the tumor site in a 4T1 murine breast cancer xenograft model, leading to promising anti‐cancer effects. In addition, the side effects of DOX were significantly diminished in the NPs at a high dose. The prepared linear‐dendritic conjugate could be used as an efficient and safe nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Institution of Radiology and Medical Imaging, Huaxi MR Research Center (HMRRC), Department of Thoracic Surgery and Institute of Thoracic Oncology, Frontiers Science Center for Disease-Related Mo…
- Psychoradiology Key Laboratory of Sichuan Province, West China Hospital, Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Sichuan University, Chengdu, China.
ORCID-Profile: Kui Luo
Förderung
- Natural Science Foundation of China
- Department of Science and Technology of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Xiang, P., Li, Y., Wu, Y., Cai, H., & Luo, K. (2026). Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine. Macromolecular Rapid Communications, 47(11). https://doi.org/10.1002/marc.70258
Vancouver
Wang Y, Xiang P, Li Y, Wu Y, Cai H, Luo K. Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine. Macromolecular Rapid Communications. 2026;47(11). doi:10.1002/marc.70258
BibTeX
@article{Wang2026,
author = {Wang, Yongchao and Xiang, Pan and Li, Yinggang and Wu, Yahui and Cai, Hao and Luo, Kui},
title = {Tumor Microenvironmental Stimuli‐Responsive Linear‐Dendritic Polymeric Conjugate as Potential Nanomedicine},
journal = {Macromolecular Rapid Communications},
year = {2026},
volume = {47},
number = {11},
doi = {10.1002/marc.70258}
}
EUVIMED